These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11700160)

  • 1. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.
    Pirro M; Bergeron J; Dagenais GR; Bernard PM; Cantin B; Després JP; Lamarche B
    Arch Intern Med; 2001 Nov; 161(20):2474-80. PubMed ID: 11700160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study.
    St-Pierre AC; Cantin B; Bergeron J; Pirro M; Dagenais GR; Després JP; Lamarche B
    Atherosclerosis; 2005 Oct; 182(2):315-21. PubMed ID: 16159604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).
    St-Pierre AC; Bergeron J; Pirro M; Cantin B; Dagenais GR; Després JP; Lamarche B;
    Am J Cardiol; 2003 Mar; 91(5):555-8. PubMed ID: 12615259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?
    Lowe GD; Yarnell JW; Rumley A; Bainton D; Sweetnam PM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):603-10. PubMed ID: 11304479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
    Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP
    JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease.
    St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Bernard PM; Després JP; Lamarche B
    Circulation; 2001 Nov; 104(19):2295-9. PubMed ID: 11696468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.
    Lamarche B; Moorjani S; Lupien PJ; Cantin B; Bernard PM; Dagenais GR; Després JP
    Circulation; 1996 Aug; 94(3):273-8. PubMed ID: 8759066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
    Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.
    Cantin B; Gagnon F; Moorjani S; Després JP; Lamarche B; Lupien PJ; Dagenais GR
    J Am Coll Cardiol; 1998 Mar; 31(3):519-25. PubMed ID: 9502629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of plasma C-reactive protein and future risk of age-related cataract.
    Schaumberg DA; Ridker PM; Glynn RJ; Christen WG; Dana MR; Hennekens CH
    Ann Epidemiol; 1999 Apr; 9(3):166-71. PubMed ID: 10192648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.